SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-15-000568
Filing Date
2015-02-17
Accepted
2015-02-17 16:19:55
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q vsta10q_dec312014.htm 10-Q 1590186
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER REQUIRED BY RULE 13A-14(A) UNDE ex31-1.htm EX-31.1 9710
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER REQUIRED BY RULE 13A-14(A) UNDE ex31-2.htm EX-31.2 10646
4 CERTIFICATION OF THE PRINCIPAL EXECUTIVE AND FINANCIAL OFFICERS REQUIRED BY RULE ex32.htm EX-32 6188
  Complete submission text file 0001415889-15-000568.txt   6884661

Data Files

Seq Description Document Type Size
5 vsta-20141231.xml EX-101.INS 981319
6 vsta-20141231.xsd EX-101.SCH 51017
7 vsta-20141231_cal.xml EX-101.CAL 45040
8 vsta-20141231_def.xml EX-101.DEF 155247
9 vsta-20141231_lab.xml EX-101.LAB 286525
10 vsta-20141231_pre.xml EX-101.PRE 239816
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54014 | Film No.: 15622804
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences